Paper39239090
Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline.
Haidar G and 8 others. JAC Antimicrob Resist, 2024. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline. Papers, record 39239090. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39239090
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Emergence of high-level aztreonam-avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 AI154546 | NIAID NIH HHS | United States | K23AI154546 | PubMed and NIH | NIH RePORTER |
| R03 HL162655 | NHLBI NIH HHS | United States | R03HL162655 | PubMed | NIH RePORTER |
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33970222 | Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/33970222 | PubMed |
| 2 | 34223033 | Escherichia coli strains possessing a four amino acid YRIN insertion in PBP3 identified as part of the SIDERO-WT-2014 surveillance study. | JAC Antimicrob Resist | 2020 | https://conductscience.org/library/papers/34223033 | PubMed |
| 3 | 35867524 | NDM-35-Producing ST167 Escherichia coli Highly Resistant to β-Lactams Including Cefiderocol. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/35867524 | PubMed |
| 4 | 31828337 | Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study. | J Antimicrob Chemother | 2020 | https://conductscience.org/library/papers/31828337 | PubMed |
| 5 | 34545787 | New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria, Switzerland, 2019-2020. | Emerg Infect Dis | 2021 | https://conductscience.org/library/papers/34545787 | PubMed |
| 6 | 36968951 | Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producing K. pneumoniae clinical isolates. | JAC Antimicrob Resist | 2023 | https://conductscience.org/library/papers/36968951 | PubMed |
| 7 | 35815680 | Evolution of β-lactamase-mediated cefiderocol resistance. | J Antimicrob Chemother | 2022 | https://conductscience.org/library/papers/35815680 | PubMed |
| 8 | 37416757 | An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance. | Open Forum Infect Dis | 2023 | https://conductscience.org/library/papers/37416757 | PubMed |
| 9 | 32988825 | Genetic Features Leading to Reduced Susceptibility to Aztreonam-Avibactam among Metallo-β-Lactamase-Producing Escherichia coli Isolates. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32988825 | PubMed |
| 10 | 37463564 | Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/37463564 | PubMed |
| 11 | 32464664 | Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model. | J Antimicrob Chemother | 2020 | https://conductscience.org/library/papers/32464664 | PubMed |
| 12 | 25634992 | Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3. | J Antimicrob Chemother | 2015 | https://conductscience.org/library/papers/25634992 | PubMed |
| 13 | 32427286 | Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32427286 | PubMed |
| 14 | 28559260 | Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested In Vitro with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28559260 | PubMed |
| 15 | 37610183 | Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France. | Emerg Infect Dis | 2023 | https://conductscience.org/library/papers/37610183 | PubMed |
| 16 | 25022578 | Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25022578 | PubMed |
| 17 | 28381609 | Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae. | J Clin Microbiol | 2017 | https://conductscience.org/library/papers/28381609 | PubMed |
| 18 | 38661186 | The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam? | Clin Infect Dis | 2024 | https://conductscience.org/library/papers/38661186 | PubMed |
| 19 | 37250794 | The upper and lower respiratory tract microbiome in severe aspiration pneumonia. | iScience | 2023 | https://conductscience.org/library/papers/37250794 | PubMed |
| 20 | 34618008 | Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/34618008 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938727 | Carbapenemases in Gram-Negative Bacilli: Classification, Detection, Therapeutic Options, and Resistance to Novel Antimicrobials. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42938727 | PubMed |
| 42921071 | Molecular characterization of carbapenemase-producing Enterobacterales from Peshawar City, Khyber Pakhtunkhwa, Pakistan. | JAC Antimicrob Resist | 2026 | https://conductscience.org/library/papers/42921071 | PubMed |
| 42876900 | The global epidemiology and treatment of metallo-β-lactamase-producing gram-negative pathogens. | JAC Antimicrob Resist | 2026 | https://conductscience.org/library/papers/42876900 | PubMed |
| 42714383 | Impact of PBP3 insertions and β-lactamase-encoding genes on the susceptibility of Escherichia coli isolates belonging to high-risk clones against aztreonam-avibactam and comparator agents. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42714383 | PubMed |
| 42593110 | Outbreak of aztreonam-avibactam-resistant NDM-5-producing Escherichia coli isolates in a hospital of Paris. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42593110 | PubMed |
| 42191848 | Aztreonam-avibactam at the frontline: A dual-agent approach to metallo-β-lactamase resistance. | J Antibiot (Tokyo) | 2026 | https://conductscience.org/library/papers/42191848 | PubMed |
| 42041376 | Clinically Significant Carbapenemases in Gram-Negative Pathogens: Molecular Diversity and Advances in β-Lactamase Inhibitor Therapy. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42041376 | PubMed |
| 41972762 | Beneficial impact of acquired AmpC β-lactamases on bacterial fitness and pathogenicity: a new paradigm. | mBio | 2026 | https://conductscience.org/library/papers/41972762 | PubMed |
| 41891866 | Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41891866 | PubMed |
| 41837290 | The bug, the burden, and the biology: beyond host-centric phenotyping in sepsis. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41837290 | PubMed |
| 41805189 | Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41805189 | PubMed |
| 41705828 | In vitro activity of aztreonam-avibactam and distribution of carbapenemase genes in ceftazidime-avibactam-resistant carbapenem-resistant Enterobacterales: data from the global Antimicrobial Testing Leadership and Surveillance, 2019-2023. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41705828 | PubMed |
| 41665356 | High in vitro activity of aztreonam/avibactam against NDM-producing Enterobacterales with emerging resistance in Escherichia coli in the United States Mid-Atlantic region. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41665356 | PubMed |
| 41608681 | Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41608681 | PubMed |
| 41577890 | Aztreonam plus ceftazidime/avibactam broth disk elution test: failure to detect Escherichia coli with PBP-3 insertions. | Eur J Clin Microbiol Infect Dis | 2026 | https://conductscience.org/library/papers/41577890 | PubMed |
| 41522717 | Management of infections caused by carbapenemase-producing Enterobacterales in France: a real-world study. | JAC Antimicrob Resist | 2026 | https://conductscience.org/library/papers/41522717 | PubMed |
| 41455885 | Genomic characterization and comparative analysis of multidrug-resistant Escherichia coli ST361 from urban wetland. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/41455885 | PubMed |
| 41301604 | Use of Aztreonam-Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41301604 | PubMed |
| 41032192 | NDM-5 and siderophore receptor mutations drive high-level cefiderocol resistance in Klebsiella pneumoniae: a case series. | Infection | 2026 | https://conductscience.org/library/papers/41032192 | PubMed |
| 40724005 | Mechanisms of Cefiderocol Resistance in Carbapenemase-Producing Enterobacterales: Insights from Comparative Genomics. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40724005 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39239090
GET https://conductscience.org/api/papers/v1/39239090/references?page=2